{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:10:00Z","timestamp":1777468200974,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.lfs.2019.117039","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T23:10:02Z","timestamp":1572995402000},"page":"117039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Altered cyclooxygenase-1 and enhanced thromboxane receptor activities underlie attenuated endothelial dilatory capacity of omental arteries in obesity"],"prefix":"10.1016","volume":"239","author":[{"given":"Asmaa","family":"Raees","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysha","family":"Bakhamis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidya","family":"Mohamed-Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moataz","family":"Bashah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mashael","family":"Al-Jaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie H.","family":"Clapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson N.","family":"Orie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2019.117039_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/cob.12082","article-title":"Obesity and symptoms of depression among adults in selected countries of the Middle East: a systematic review and meta-analysis","volume":"5","author":"Abou Abbas","year":"2015","journal-title":"Clin. Obes."},{"key":"10.1016\/j.lfs.2019.117039_bib2","author":"World health statistics"},{"issue":"3","key":"10.1016\/j.lfs.2019.117039_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.9734\/BJMMR\/2012\/1479","article-title":"Endothelial dysfunction: an early cardiovascular risk marker in asymptomatic obese individuals with prediabetes","volume":"2","author":"Gupta","year":"2012","journal-title":"Br. J. Med. Med. Res."},{"issue":"6","key":"10.1016\/j.lfs.2019.117039_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/edrv.21.6.0415","article-title":"Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome","volume":"21","author":"Wajchenberg","year":"2000","journal-title":"Endocr. Rev."},{"issue":"11_supplement_1","key":"10.1016\/j.lfs.2019.117039_bib5","doi-asserted-by":"crossref","first-page":"s57","DOI":"10.1210\/jc.2008-1585","article-title":"Role of body fat distribution and the metabolic complications of obesity","volume":"93","author":"Jensen","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.lfs.2019.117039_bib6","doi-asserted-by":"crossref","first-page":"E1262","DOI":"10.1152\/ajpendo.90511.2008","article-title":"RANTES release by human adipose tissue in vivo and evidence for depot-specific differences","volume":"296","author":"Madani","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.lfs.2019.117039_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/oby.20505","article-title":"Cyclooxygenase inhibition improves endothelial vasomotor dysfunction of visceral adipose arterioles in human obesity","volume":"22","author":"Farb","year":"2014","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.lfs.2019.117039_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/oxfordjournals.bmb.a071832","article-title":"The prostacyclin-thromboxane A2 balance: pathophysiological and therapeutic implications","volume":"39","author":"Bunting","year":"1983","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.lfs.2019.117039_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1152\/physiolgenomics.00136.2007","article-title":"Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension","volume":"32","author":"Tang","year":"2008","journal-title":"Physiol. Genom."},{"issue":"3","key":"10.1016\/j.lfs.2019.117039_bib10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1476-5381.2009.00553.x","article-title":"Altered arachidonic acid metabolism via COX-1 and COX-2 contributes to the endothelial dysfunction of penile arteries from obese Zucker rats","volume":"159","author":"Sanchez","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.lfs.2019.117039_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/hh2001.098351","article-title":"Prostaglandin H synthase and vascular function","volume":"89","author":"Davidge","year":"2001","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.lfs.2019.117039_bib12","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.4049\/jimmunol.167.5.2831","article-title":"Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2","volume":"167","author":"Caughey","year":"2001","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.lfs.2019.117039_bib13","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1161\/01.ATV.18.12.1922","article-title":"Upregulation of prostacyclin synthesis-related gene expression by shear stress in vascular endothelial cells","volume":"18","author":"Okahara","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"19","key":"10.1016\/j.lfs.2019.117039_bib14","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.93.19.10417","article-title":"Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress","volume":"93","author":"Topper","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2019.117039_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.RES.83.4.353","article-title":"Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity","volume":"83","author":"Camacho","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2019.117039_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0090-6980(02)00028-X","article-title":"Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2","volume":"68\u201369","author":"Loftin","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.lfs.2019.117039_bib17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/01.fjc.0000187174.67661.67","article-title":"Endothelium-dependent contractions occur in the aorta of wild-type and COX2-\/- knockout but not COX1-\/- knockout mice","volume":"46","author":"Tang","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2019.117039_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cardiores.2005.04.008","article-title":"COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db\/db mice","volume":"67","author":"Guo","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.lfs.2019.117039_bib19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.HYP.0000085650.29823.F2","article-title":"Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney","volume":"42","author":"Quilley","year":"2003","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.lfs.2019.117039_bib20","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1007\/s00125-016-4031-3","article-title":"Interleukin-6 induces impairment in human subcutaneous adipogenesis in obesity-associated insulin resistance","volume":"59","author":"Almuraikhy","year":"2016","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.lfs.2019.117039_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cardiores.2005.08.004","article-title":"Evidence that inward rectifier K+ channels mediate relaxation by the PGI2 receptor agonist cicaprost via a cyclic AMP-independent mechanism","volume":"69","author":"Orie","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.lfs.2019.117039_bib22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejphar.2010.12.005","article-title":"Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: evidence for Gi\/o modulation via EP3 receptors","volume":"654","author":"Orie","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2019.117039_bib23","series-title":"Adipose Tissue Protocols","first-page":"155","article-title":"Differentiation of adipose stem cells","author":"Bunnell","year":"2008"},{"issue":"7","key":"10.1016\/j.lfs.2019.117039_bib24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.lfs.2019.117039_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-2999(93)90378-U","article-title":"The anti-platelet actions of FR122047, a novel cyclooxygenase inhibitor","volume":"243","author":"Dohi","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2019.117039_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(00)00051-0","article-title":"The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models","volume":"391","author":"Ochi","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2019.117039_bib27","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0960-894X(03)00046-5","article-title":"3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubility","volume":"13","author":"Black","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.lfs.2019.117039_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejmech.2017.09.056","article-title":"Discovery of new indomethacin-based analogs with potentially selective cyclooxygenase-2 inhibition and observed diminishing to PGE2 activities","volume":"141","author":"Kassab","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2019.117039_bib29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/jc.2018-00512","article-title":"Microvascular endothelial dysfunction in human obesity: role of TNF-alpha","volume":"104","author":"Virdis","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.lfs.2019.117039_bib30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/ATVBAHA.111.235846","article-title":"Arteriolar function in visceral adipose tissue is impaired in human obesity","volume":"32","author":"Farb","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.lfs.2019.117039_bib31","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1476-5381.1981.tb16814.x","article-title":"Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations","volume":"73","author":"Coleman","year":"1981","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2019.117039_bib32","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1097\/00004872-200211000-00024","article-title":"Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression","volume":"20","author":"Traupe","year":"2002","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.lfs.2019.117039_bib33","doi-asserted-by":"crossref","first-page":"H319","DOI":"10.1152\/ajpheart.00022.2014","article-title":"Vasoconstrictor role of cyclooxygenase-1-mediated prostacyclin synthesis in non-insulin-dependent diabetic mice induced by high-fat diet and streptozotocin","volume":"307","author":"Zhu","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2019.117039_bib34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/clpt.2009.108","article-title":"COX-1 and vascular disease","volume":"86","author":"Vanhoutte","year":"2009","journal-title":"Clin. Pharmacol. Therapeut."},{"issue":"1","key":"10.1016\/j.lfs.2019.117039_bib35","doi-asserted-by":"crossref","first-page":"F120","DOI":"10.1152\/ajprenal.00111.2007","article-title":"Altered TP receptor function in isolated, perfused kidneys of nondiabetic and diabetic ApoE-deficient mice","volume":"294","author":"Michel","year":"2008","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"5","key":"10.1016\/j.lfs.2019.117039_bib36","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1159\/000485817","article-title":"Sildenafil (viagra(R)) prevents cox-1\/TXA2 pathway-mediated vascular hypercontractility in ApoE-\/- mice","volume":"44","author":"Leal","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.lfs.2019.117039_bib37","doi-asserted-by":"crossref","first-page":"H1978","DOI":"10.1152\/ajpheart.01318.2007","article-title":"Sympathy for the devil: the role of thromboxane in the regulation of vascular tone and blood pressure","volume":"294","author":"Sellers","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2019.117039_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pharmthera.2004.06.003","article-title":"Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation","volume":"103","author":"Hata","year":"2004","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.lfs.2019.117039_bib39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/abbi.1997.0348","article-title":"Nitric oxide modulates the activity of the hemoproteins prostaglandin I2 synthase and thromboxane A2 synthase","volume":"347","author":"Wade","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.lfs.2019.117039_bib40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1472-8206.2008.00610.x","article-title":"Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans","volume":"22","author":"Bellien","year":"2008","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2019.117039_bib41","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00005344-199611000-00014","article-title":"The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation","volume":"28","author":"Shimokawa","year":"1996","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117039_bib42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.bjp.0703041","article-title":"Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries","volume":"129","author":"Buus","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117039_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1933719106298197","article-title":"Regulation of endothelial-dependent relaxation in human systemic arteries by SKCa and IKCa channels","volume":"14","author":"Gillham","year":"2007","journal-title":"Reprod. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2019.117039_bib44","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.bjp.0704143","article-title":"Endothelium-derived hyperpolarizing factor and potassium use different mechanisms to induce relaxation of human subcutaneous resistance arteries","volume":"133","author":"McIntyre","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.lfs.2019.117039_bib45","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1161\/01.CIR.94.12.3341","article-title":"Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor","volume":"94","author":"Bauersachs","year":"1996","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2019.117039_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/bjp.2008.256","article-title":"Hypertension and the absence of EDHF-mediated responses favour endothelium-dependent contractions in renal arteries of the rat","volume":"155","author":"Michel","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117039_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.bjp.0705756","article-title":"Thromboxane receptor stimulation associated with loss of SKCa activity and reduced EDHF responses in the rat isolated mesenteric artery","volume":"142","author":"Crane","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2019.117039_bib48","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1476-5381.1996.tb15765.x","article-title":"Endothelium-derived factors and hyperpolarization of the carotid artery of the Guinea-pig","volume":"119","author":"Corriu","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.lfs.2019.117039_bib49","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1161\/01.CIR.103.12.1702","article-title":"Endothelium-derived hyperpolarizing factor : identification and mechanisms of action in human subcutaneous resistance arteries","volume":"103","author":"Coats","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.lfs.2019.117039_bib50","first-page":"H1107","article-title":"Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium","volume":"276","author":"Doughty","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"Pt 3","key":"10.1016\/j.lfs.2019.117039_bib51","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1113\/jphysiol.1995.sp021086","article-title":"Apamin-sensitive K+ channels mediate an endothelium-dependent hyperpolarization in rabbit mesenteric arteries","volume":"489","author":"Murphy","year":"1995","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117039_bib52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.bjp.0701108","article-title":"Involvement of voltage-dependent potassium channels in the EDHF-mediated relaxation of rat hepatic artery","volume":"121","author":"Zygmunt","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2019.117039_bib53","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2337\/diabetes.49.6.883","article-title":"The perils of portliness: causes and consequences of visceral adiposity","volume":"49","author":"Montague","year":"2000","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.lfs.2019.117039_bib54","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2337\/db06-1656","article-title":"Visceral fat adipokine secretion is associated with systemic inflammation in obese humans","volume":"56","author":"Fontana","year":"2007","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.lfs.2019.117039_bib55","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.lfs.2019.117039_bib56","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCRESAHA.108.173963","article-title":"Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1","volume":"103","author":"Yan","year":"2008","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.lfs.2019.117039_bib57","doi-asserted-by":"crossref","first-page":"H1982","DOI":"10.1152\/ajpheart.01261.2007","article-title":"Role of EDHF in type 2 diabetes-induced endothelial dysfunction","volume":"295","author":"Park","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.lfs.2019.117039_bib58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000079706","article-title":"Role of JAK\/STAT pathway in IL-6-induced activation of vascular smooth muscle cells","volume":"24","author":"Watanabe","year":"2004","journal-title":"Am. J. Nephrol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051930966X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051930966X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:30:53Z","timestamp":1758400253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432051930966X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":58,"alternative-id":["S002432051930966X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117039","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered cyclooxygenase-1 and enhanced thromboxane receptor activities underlie attenuated endothelial dilatory capacity of omental arteries in obesity","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117039"}}